{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:46:29Z","timestamp":1793652389674,"version":"4.5.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12888-018-1824-6","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T08:14:15Z","timestamp":1533024855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":211,"title":["Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-6860","authenticated-orcid":false,"given":"Timothy I.","family":"Michaels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Purdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monnica T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"1824_CR1","volume-title":"Plants of the gods\u00a0: origins of hallucinogenic use TT","author":"RE Schultes","year":"1979","unstructured":"Schultes RE, Hofmann A. Plants of the gods\u00a0: origins of hallucinogenic use TT. New York: A McGraw-hill co-publication TA; 1979."},{"key":"1824_CR2","doi-asserted-by":"crossref","unstructured":"Sessa B. The History of Psychedelics in Medicine. In: von Heyden M., Jungaberle H., Maji\u0107 T. (eds) Handbuch Psychoaktive Substanzen. Springer Reference Psychologie. Berlin: Springer; 2016.","DOI":"10.1007\/978-3-642-55214-4_96-1"},{"key":"1824_CR3","doi-asserted-by":"crossref","unstructured":"George JR, Michaels TI, Sevelius J, Williams MT. The psychedelic renaissance and the limitations ofa white-dominant medical framework:a call for indigenous and minority inclusion. In: Williams MT, Rosen D, Kanter J, editors. Elimin Ment Heal Disparities: New Harbinger Press; 2018.","DOI":"10.1556\/2054.2019.015"},{"key":"1824_CR4","unstructured":"Sevelius J. How psychedelic science privileges some, neglects others, and limits us all. Chacruna. 2017;1. Available online at \n                    http:\/\/chacruna.net\/how-psychedelic-science-privileges-some-neglects-others\/\n                    \n                  ."},{"key":"1824_CR5","first-page":"1","volume":"27","author":"C Barton","year":"2017","unstructured":"Barton C. The elephant in the room: the need to address race in psychedelic research. MAPS Bull. 2017;27:1\u20133.","journal-title":"MAPS Bull"},{"key":"1824_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.00172","volume":"9","author":"LR Swanson","year":"2018","unstructured":"Swanson LR. Unifying theories of psychedelic drug effects. Front Pharmacol. 2018;9:1\u201323.","journal-title":"Front Pharmacol"},{"key":"1824_CR7","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Mu\u00f1oz F, Alamo C, Cuenca E, Shen WW, Clervoy P, Rubio G. History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry. 2005;17(3):113-35.","DOI":"10.1080\/10401230591002002"},{"key":"1824_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"M Johnson","year":"2008","unstructured":"Johnson M, Richards W, Griffiths R. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008;22:603\u201320.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1824_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/02791072.1991.10472572","volume":"23","author":"RJ Strassman","year":"1991","unstructured":"Strassman RJ. Human hallucinogenic drug research in the United States: a present-day case history and review of the process. J Psychoactive Drugs. 1991;23(1):29\u201338.","journal-title":"J Psychoactive Drugs"},{"key":"1824_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02791072.2014.877321","volume":"46","author":"A Emerson","year":"2014","unstructured":"Emerson A, Pont\u00e9 L, Jerome L, Doblin R. History and future of the multidisciplinary Association for Psychedelic Studies (MAPS). J Psychoactive Drugs. 2014;46:27\u201336.","journal-title":"J Psychoactive Drugs"},{"key":"1824_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3122\/jabfm.2011.04.100280","volume":"24","author":"L Leung","year":"2011","unstructured":"Leung L. Cannabis and its derivatives: review of medical use. J Am Board Fam Med. 2011;24:452\u201362.","journal-title":"J Am Board Fam Med"},{"key":"1824_CR12","first-page":"495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen F, M\u00fcller-Vahl K. The therapeutic potential of Cannabis. Dtsch Arztebl Int. 2012;109:495\u2013501.","journal-title":"Dtsch Arztebl Int"},{"key":"1824_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","volume":"12","author":"G Serafini","year":"2014","unstructured":"Serafini G, Howland RH, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol. 2014;12:444\u201361.","journal-title":"Curr Neuropharmacol"},{"key":"1824_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","volume":"3","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M, et al. Psilocybin with pyschological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016;3:619\u201327.","journal-title":"Lancet Psychiatry"},{"key":"1824_CR15","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","volume":"67","author":"FA Moreno","year":"2006","unstructured":"Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry. 2006;67:1735\u201340.","journal-title":"J Clin Psychiatry"},{"key":"1824_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. Johnson, Matthew W., Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, US, 21224\u20136823: Sage Publications. 2014;28:983\u201392.","journal-title":"J Psychopharmacol"},{"key":"1824_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","volume":"29","author":"P Gasser","year":"2015","unstructured":"Gasser P, Kirchner K, Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol. 2015;29:57\u201368.","journal-title":"J Psychopharmacol"},{"key":"1824_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","volume":"202","author":"P Gasser","year":"2014","unstructured":"Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, et al. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014;202:513\u201320.","journal-title":"J Nerv Ment Dis"},{"key":"1824_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1874473708666150107120011","volume":"7","author":"M Winkelman","year":"2014","unstructured":"Winkelman M. Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. Curr. Drug Abuse Rev. 2014;7:101\u201316.","journal-title":"Curr. Drug Abuse Rev"},{"key":"1824_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","volume":"36","author":"RF Sanches","year":"2016","unstructured":"Sanches RF, de Lima OF, dos Santos RG, Macedo LRH, Maia-de-Oliveira JP, Wichert-Ana L, et al. Antidepressant effects of a single dose of Ayahuasca in patients with recurrent depression. J Clin Psychopharmacol. 2016;36:77\u201381.","journal-title":"J Clin Psychopharmacol"},{"key":"1824_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/15733998113099990003","volume":"6","author":"G Thomas","year":"2013","unstructured":"Thomas G, Lucas P, Capler N, Tupper K, Martin G. Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev. 2013;6:30\u201342.","journal-title":"Curr Drug Abuse Rev"},{"key":"1824_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0269881112464827","volume":"27","author":"P Oehen","year":"2013","unstructured":"Oehen P, Traber R, Widmer V, Schnyder U. A randomized, controlled pilot study of MDMA (\u00b13,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013;27:40\u201352.","journal-title":"J Psychopharmacol"},{"key":"1824_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0269881110378371","volume":"25","author":"MC Mithoefer","year":"2011","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. The safety and efficacy of \u00b13,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol. 2011;25:439\u201352.","journal-title":"J Psychopharmacol"},{"key":"1824_CR24","unstructured":"Williams MT, Leins C. Race-based trauma: The challenge and promise of MDMA-assisted psychotherapy. Multidiscip Assoc Psychedelic Stud Bull. 2016;26(1)."},{"key":"1824_CR25","volume-title":"Cultural variations in psychopathology: from research to practice","author":"S Barnow","year":"2013","unstructured":"Barnow S, Balkir N. In: Barnow S, Balkir N, editors. Cultural variations in psychopathology: from research to practice. Cambridge: Hogrefe Publishing; 2013."},{"issue":"4","key":"1824_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mpr.178","volume":"13","author":"M Alegria","year":"2004","unstructured":"Alegria M, Takeuchi D, Canino G, Duan N, Shrout P, Meng XL, et al. Considering context, place and culture: The National Latino and Asian American Study. Int J Methods Psychiatr Res. 2004;13(4):208\u201320.","journal-title":"Int J Methods Psychiatr Res"},{"key":"1824_CR27","doi-asserted-by":"crossref","unstructured":"Alegria M, Jackson JS, Kessler RC, et al. Collaborative Psychiatric Epidemiologic Surveys (CPES), 2001\u20132003 (United States) Ann Arbor, MI: Inter-university Consortium for Political and Social Research; 2008.","DOI":"10.3886\/ICPSR20240.v6"},{"key":"1824_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/S0033291705006161","volume":"36","author":"J Breslau","year":"2006","unstructured":"Breslau J, Aguilar-Gaxiola S, Kendler KS, Su M, Williams D, Kessler RC. Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychol Med. 2006;36:57\u201368.","journal-title":"Psychol Med"},{"key":"1824_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2105\/AJPH.2006.088401","volume":"97","author":"DT Takeuchi","year":"2007","unstructured":"Takeuchi DT, Zane N, Hong S, Chae DH, Gong F, Gee GC, et al. Immigration-related factors and mental disorders among Asian Americans. Am J Public Health. 2007;97:84\u201390.","journal-title":"Am J Public Health"},{"key":"1824_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jocrd.2016.04.008","volume":"10","author":"KD Wu","year":"2016","unstructured":"Wu KD, Wyman SV. Examination of racial differences in assessment of OCD symptoms and obsessive beliefs. J Obsessive Compuls Relat Disord. Elsevier. 2016;10:10\u20138.","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"1824_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/mpr.180","volume":"13","author":"B-E Pennell","year":"2004","unstructured":"Pennell B-E, Bowers A, Carr D, Chardoul S, Cheung G-Q, Dinkelmann K, et al. The development and implementation of the National Comorbidity Survey Replication, the National Survey of American life, and the National Latino and Asian American survey. Int J Methods Psychiatr Res. 2004;13:241\u201369.","journal-title":"Int J Methods Psychiatr Res"},{"key":"1824_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593\u2013602.","journal-title":"Arch Gen Psychiatry"},{"key":"1824_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.janxdis.2012.02.009","volume":"26","author":"MT Williams","year":"2012","unstructured":"Williams MT, Domanico J, Marques L, Leblanc NJ, Turkheimer E. Barriers to treatment among African Americans with obsessive-compulsive disorder. J Anxiety Disord. 2012;26:555\u201363.","journal-title":"J Anxiety Disord"},{"key":"1824_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1037\/ort0000188","volume":"87","author":"MT Williams","year":"2017","unstructured":"Williams MT, Jahn ME. Obsessive-compulsive disorder in African American children and adolescents: risks, resiliency, and barriers to treatment. Am J Orthop. 2017;87:291\u2013303.","journal-title":"Am J Orthop"},{"key":"1824_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cct.2011.09.001","volume":"33","author":"MT Williams","year":"2012","unstructured":"Williams MT, Proetto D, Casiano D, Franklin ME. Recruitment of a hidden population: African Americans with obsessive-compulsive disorder. Contemp Clin Trials. 2012;33:67\u201375.","journal-title":"Contemp Clin Trials"},{"key":"1824_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.janxdis.2012.02.011","volume":"26","author":"DB Mendoza","year":"2012","unstructured":"Mendoza DB, Williams MT, Chapman KL, Powers M. Minority inclusion in randomized clinical trials of panic disorder. J Anxiety Disord. 2012;26:574\u201382.","journal-title":"J Anxiety Disord."},{"issue":"4","key":"1824_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mpr.177","volume":"13","author":"JS Jackson","year":"2004","unstructured":"Jackson JS, Torres M, Caldwell CH, Neighbors HW, Nesse RM, Taylor RJ, et al. The National Survey of American Life: A study of racial, ethnic and cultural influences on mental disorders and mental health. Int J Methods Psychiatr Res. 2004;13(4):196\u2013207.","journal-title":"Int J Methods Psychiatr Res"},{"key":"1824_CR38","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1176\/ps.62.10.pss6210_1167","volume":"62","author":"IM Lesser","year":"2011","unstructured":"Lesser IM, Zisook S, Gaynes BN, Wisniewski SR, Luther JF, Fava M, et al. Effects of race and ethnicity on depression treatment outcomes: The CO-MED trial. Psychiatr Serv. Lesser, Ira M., Department of Psychiatry, Harbor-UCLA Medical Center, Box 8, 1000 West Carson St., M\/C 176847, Torrance, CA, US, 90509: American Psychiatric Assn. 2011;62:1167\u201379.","journal-title":"Psychiatr Serv"},{"key":"1824_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1037\/a0017864","volume":"7","author":"K Youman","year":"2010","unstructured":"Youman K, Drapalski A, Stuewig J, Bagley K, Tangney J. Race differences in psychopathology and disparities in treatment seeking: community and jail-based treatment-seeking patterns. Psychol Serv. 2010;7:11\u201326.","journal-title":"Psychol Serv"},{"key":"1824_CR40","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1017\/S0033291710002291","volume":"41","author":"R Mojtabai","year":"2011","unstructured":"Mojtabai R, Olfson M, Sampson NA, Jin R, Druss B, Wang PS, et al. Barriers to mental health treatment: results from the National Comorbidity Survey Replication. Psychol Med. 2011;41:1751\u201361.","journal-title":"Psychol Med"},{"key":"1824_CR41","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1353\/hpu.2006.0126","volume":"17","author":"RV Katz","year":"2006","unstructured":"Katz RV, Kegeles SS, Kressin NR, Green BL, Wang MQ, James SA, et al. The Tuskegee legacy project: willingness of minorities to participate in biomedical research. J Health Care Poor Underserved. 2006;17:698\u2013715.","journal-title":"J Health Care Poor Underserved"},{"key":"1824_CR42","first-page":"265","volume-title":"The black seventies","author":"C Pierce","year":"1970","unstructured":"Pierce C. Offensive Mechanisms. In: Barbour F, editor. The black seventies. Boston: Porter Sargent; 1970. p. 265\u201382."},{"key":"1824_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1146\/annurev.psych.60.110707.163651","volume":"60","author":"S Sue","year":"2009","unstructured":"Sue S, Zane N, Nagayama Hall GC, Berger LK. The case for cultural competency in psychotherapeutic interventions. Annu Rev Psychol. 2009;60:525\u201348.","journal-title":"Annu Rev Psychol"},{"key":"1824_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1037\/cou0000077","volume":"62","author":"L Torres","year":"2015","unstructured":"Torres L, Taknint JT. Ethnic microaggressions, traumatic stress symptoms, and Latino Depression\u00a0: a moderated Mediational model. J Couns Psychol. 2015;62:393\u2013401.","journal-title":"J Couns Psychol"},{"key":"1824_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/a0025432","volume":"18","author":"T Chou","year":"2012","unstructured":"Chou T, Asnaani A, Hofmann SG. Perception of racial discrimination and psychopathology across three U.S. ethnic minority groups. Cult Divers Ethn Minor Psychol. 2012;18:74\u201381.","journal-title":"Cult Divers Ethn Minor Psychol"},{"key":"1824_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.janxdis.2010.09.011","volume":"25","author":"JA Soto","year":"2011","unstructured":"Soto JA, Dawson-Andoh NA, BeLue R. The relationship between perceived discrimination and generalized anxiety disorder among African Americans, afro Caribbeans, and non-Hispanic whites. J Anxiety Disord. 2011;25:258\u201365.","journal-title":"J Anxiety Disord."},{"key":"1824_CR47","first-page":"209","volume-title":"PTSD among African Americans","author":"IM Allen","year":"1996","unstructured":"Allen IM. In: Marsella AJ, editor. PTSD among African Americans; 1996. p. 209\u201338."},{"key":"1824_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1037\/0022-0167.54.2.142","volume":"54","author":"MG Constantine","year":"2007","unstructured":"Constantine MG, Sue DW. Perceptions of racial microaggressions among black supervisees in cross-racial dyads. J Couns Psychol. 2007;54:142\u201353.","journal-title":"J Couns Psychol"},{"issue":"1","key":"1824_CR49","first-page":"31","volume":"199","author":"MT Williams","year":"2012","unstructured":"Williams MT, Chapman LK, Wong J, Turkheimer E. The role of ethnic identity in symptoms of anxiety and depression in African Americans. role Ethn. identity symptoms anxiety Depress. African Am. 2012;199(1):31\u20136.","journal-title":"African Am"},{"key":"1824_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1024500514834","volume":"26","author":"JS Phinney","year":"1997","unstructured":"Phinney JS, Lou CC, Kurtz DA. Ethnic and American identity as predictors of self-esteem among African American, Latino, and white adolescents. J Youth Adolesc. 1997;26:165\u201385.","journal-title":"J Youth Adolesc"},{"key":"1824_CR51","first-page":"1408","volume":"59","author":"National Institutes of Health","year":"1994","unstructured":"National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist. 1994;59:1408\u201313.","journal-title":"Fed Regist"},{"key":"1824_CR52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1037\/0022-006X.64.5.851","volume":"64","author":"AA Hohmann","year":"1996","unstructured":"Hohmann AA, Parron DL. How the new NIH guidelines on inclusion of women and minorities apply: efficacy trials, effectiveness trials, and validity. J Consult Clin Psychol. 1996;64:851\u20135.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"1824_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cct.2006.05.012","volume":"27","author":"GM Corbie-Smith","year":"2006","unstructured":"Corbie-Smith GM, Durant RW, St. DMM G. Investigators\u2019 assessment of NIH mandated inclusion of women and minorities in research. Contemp Clin Trials. 2006;27(6):571\u20139.","journal-title":"Contemp Clin Trials"},{"key":"1824_CR54","volume-title":"Report of the advisory committee on research on women\u2019s health","author":"National Institutes of Health","year":"2016","unstructured":"National Institutes of Health. Report of the advisory committee on research on women\u2019s health. 2016;"},{"key":"1824_CR55","doi-asserted-by":"crossref","unstructured":"Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. 2015;277:99-120.","DOI":"10.1016\/j.bbr.2014.07.016"},{"key":"1824_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0269881116677104","volume":"31","author":"CE Canal","year":"2017","unstructured":"Canal CE, Murnane KS. The serotonin 5-HT 2C receptor and the non-addictive nature of classic hallucinogens. J Psychopharmacol. 2017;31:127\u201343.","journal-title":"J Psychopharmacol"},{"key":"1824_CR57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euroneuro.2015.01.008","volume":"25","author":"JC Bouso","year":"2015","unstructured":"Bouso JC, Palhano-Fontes F, Rodr\u00edguez-Fornells A, Ribeiro S, Sanches R, Crippa JAS, et al. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol Elsevier. 2015;25:483\u201392.","journal-title":"Eur Neuropsychopharmacol Elsevier"},{"key":"1824_CR58","first-page":"1","volume":"2","author":"H Landrine","year":"2014","unstructured":"Landrine H, Corral I. Advancing research on racial-ethnic health disparities: improving measurement equivalence in studies with diverse samples. Front Public Heal. 2014;2:1\u201322.","journal-title":"Front Public Heal"},{"key":"1824_CR59","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2105\/AJPH.92.9.1471","volume":"92","author":"U Boehmer","year":"2002","unstructured":"Boehmer U, Kressin NR, Berlowitz DR, Christiansen CL, Kazis LE, Jones JA. Self-reported vs administrative race\/ethnicity data and study results. Am J Public Health. 2002;92:1471\u20133.","journal-title":"Am J Public Health"},{"key":"1824_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","volume":"37","author":"FL de Osorio","year":"2015","unstructured":"de Osorio FL, Sanches RF, Macedo LR, dos Santos RG, Maia-de-Oliveira JP, Wichert-Ana L, et al. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr. 2015;37:13\u201320.","journal-title":"Rev Bras Psiquiatr"},{"key":"1824_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0272-7358(98)00019-1","volume":"19","author":"EF Gil","year":"1999","unstructured":"Gil EF, Bob S. Culturally competent research: an ethical perspective. Clin Psychol Rev. 1999;19:45\u201355.","journal-title":"Clin Psychol Rev"},{"key":"1824_CR62","volume-title":"Collection of race and ethnicity data in clinical trials: Guidance for industry and Food and Drug Administration staff","author":"U.S. Department of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Minority Health, Office of Women\u2019s Health, Center for Drug Evaluation and Research","year":"2016","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Minority Health, Office of Women\u2019s Health, Center for Drug Evaluation and Research, et al. Collection of race and ethnicity data in clinical trials: Guidance for industry and Food and Drug Administration staff. 2016;"},{"key":"1824_CR63","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/jclp.20712","volume":"66","author":"E Morales","year":"2010","unstructured":"Morales E, Norcross JC. Evidence-based practices with ethnic minorities: strange bedfellows no more. J Clin Psychol. 2010;66:821\u20139.","journal-title":"J Clin Psychol"},{"key":"1824_CR64","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PCR, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. J Psychopharmacol. Bogenschutz, Michael P., Department of Psychiatry, Center for Psychiatric Research, University of New Mexico Health Sciences Center, MSC11 6035, 1, Albuquerque, NM, US, 87131\u20130001: Sage Publications. 2015;29:289\u201399.","journal-title":"J Psychopharmacol"},{"key":"1824_CR65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","volume":"40","author":"JC Bouso","year":"2008","unstructured":"Bouso JC, Doblin R, Farr\u00e9 M, Alc\u00e1zar M\u00c1, G\u00f3mez-Jarabo G. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoactive Drugs. 2008;40:225\u201336.","journal-title":"J Psychoactive Drugs"},{"key":"1824_CR66","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol. Ross, Stephen, NYU School of Medicine, 462 First Avenue, NBV 20E7, New York, NY, US, 10016: Sage Publications. 2016;30:1165\u201380.","journal-title":"J Psychopharmacol"},{"key":"1824_CR67","first-page":"145","volume-title":"Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research","author":"United States Department of Health and Human Services U","year":"2013","unstructured":"United States Department of Health and Human Services U. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research; 2013. p. 145\u201360."},{"key":"1824_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5). Diagnostic Stat Man Ment Disord 4th Ed TR; 2013. p. 280."},{"key":"1824_CR69","first-page":"336","volume":"30","author":"HF Butts","year":"2002","unstructured":"Butts HF. The black mask of humanity: racial\/ethnic discrimination and post-traumatic stress disorder. J Am Acad Psychiatry Law. 2002;30:336\u20139.","journal-title":"J Am Acad Psychiatry Law"},{"key":"1824_CR70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"MC Mithoefer","year":"2013","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, et al. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol. 2013;27:28\u201339.","journal-title":"J Psychopharmacol"},{"key":"1824_CR71","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1176\/ps.50.6.774","volume":"50","author":"K-M Lin","year":"1999","unstructured":"Lin K-M, Cheung F. Mental health issues for Asian Americans. Psychiatr Serv. 1999;50:774\u201380.","journal-title":"Psychiatr Serv"},{"key":"1824_CR72","doi-asserted-by":"crossref","unstructured":"Mendoza DB, Williams MT, Chapman KL, Powers M. Minority inclusion in randomized clinical trials of panic disorder. J Anxiety Disord. 2012;24(2):171-177.","DOI":"10.1016\/j.janxdis.2012.02.011"},{"key":"1824_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.psychres.2012.03.049","volume":"199","author":"MT Williams","year":"2012","unstructured":"Williams MT, Chapman LK, Wong J, Turkheimer E. The role of ethnic identity in symptoms of anxiety and depression in African Americans. Psychiatry Res. 2012;199:31\u20136.","journal-title":"Psychiatry Res"},{"key":"1824_CR74","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1037\/1040-3590.10.2.120","volume":"10","author":"RG Malgady","year":"1998","unstructured":"Malgady RG, Costantino G. Symptom severity in bilingual hispanics as a function of clinician ethnicity and language of interview. Psychol Assess. 1998;10:120\u20137.","journal-title":"Psychol Assess"},{"issue":"4","key":"1824_CR75","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1037\/0022-006X.59.4.533","volume":"59","author":"S Sue","year":"1991","unstructured":"Sue S, Fujino DC. Community mental health services for ethnic minority groups: A test of the cultural. J Consult Clin Psychol. 1991;59(4):533.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"1824_CR76","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1037\/0003-066X.62.4.271","volume":"62","author":"DW Sue","year":"2007","unstructured":"Sue DW, Capodilupo CM, Torino GC, Bucceri JM, Holder AM, Nadal KL, et al. Racial microaggressions in everyday life: implications for clinical practice. Am Psychol. 2007;62(4):271.","journal-title":"Am Psychol"},{"key":"1824_CR77","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ. LSD enhances suggestibility in healthy volunteers. Psychopharmacology (Berl). 2015;232(4):785-794.","DOI":"10.1007\/s00213-014-3714-z"},{"issue":"2","key":"1824_CR78","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/02791072.2005.10399801","volume":"37","author":"PCR Barbosa","year":"2005","unstructured":"Barbosa PCR, Giglio JS, Dalgalarrondo P. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. J Psychoactive Drugs. 2005;37(2):193\u2013201.","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"1824_CR79","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/02791072.2002.10399960","volume":"34","author":"MD de Rios","year":"2002","unstructured":"de Rios MD, Grob CS, Baker JR. Hallucinogens and redemption. J Psychoactive Drugs. 2002;34(3):239\u201348.","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"1824_CR80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/02791072.1970.10471362","volume":"3","author":"S Grof","year":"1970","unstructured":"Grof S. The use of LSD in psychotherapy. J Psychoactive Drugs. 1970;3(1):52\u201362.","journal-title":"J Psychoactive Drugs"},{"key":"1824_CR81","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","volume":"75","author":"EJ Daly","year":"2018","unstructured":"Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2018;75:139\u201348.","journal-title":"JAMA Psychiatry"},{"key":"1824_CR82","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","volume":"71","author":"A Feder","year":"2014","unstructured":"Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder. JAMA Psychiatry. 2014;71:681.","journal-title":"JAMA Psychiatry."},{"issue":"3","key":"1824_CR83","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/bdi.12487","volume":"19","author":"MF Grunebaum","year":"2017","unstructured":"Grunebaum MF, Ellis SP, Keilp JG, Moitra VK, Cooper TB, Marver JE, et al. Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial. Bipolar Disord. 2017;19(3):176\u201383.","journal-title":"Bipolar Disord"},{"key":"1824_CR84","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren D a, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Soc Biol Psychiatry. 2000;47:351\u20134.","journal-title":"Soc Biol Psychiatry"},{"key":"1824_CR85","unstructured":"Powers NB. Black Masks, Rainbow Bodies: Race and Psychedelics. Horizons 2017. New York, NY; 2017."},{"key":"1824_CR86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0027-9684(15)30083-3","volume":"105","author":"MT Williams","year":"2013","unstructured":"Williams MT, Beckmann-Mendez DA, Turkheimer E. Cultural barriers to African American participation in anxiety disorders research. J Natl Med Assoc. 2013;105:33\u201341.","journal-title":"J Natl Med Assoc"},{"key":"1824_CR87","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/002193470003000502","volume":"30","author":"BF Hatchett","year":"2000","unstructured":"Hatchett BF, Holmes K, Duran DA, Davis C. African Americans and research participation: the recruitment process. J Black Stud. 2000;30:664\u201375.","journal-title":"J Black Stud"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1824-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-018-1824-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1824-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T19:10:10Z","timestamp":1564513810000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-018-1824-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1824"],"URL":"https:\/\/doi.org\/10.1186\/s12888-018-1824-6","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"245"}}